In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Google CEO Sundar Pichai delivered the keynote address at Google’s annual I/O developer conference, where he emphasized the rapid progress his company has made on the AI front. Flanked by impressive ...

In-depth information and knowledge is yours for the asking and it can help with countless scenarios in everyday life.

Google gave an update on various aspects of its health-related R&D at its annual event The Check Up, including a new collection of artificial intelligence (AI) models intended to support drug ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Pioneering AI Transformation from Bio to Business Intelligence. SEOUL, South Korea, July 22, 2025 /PRNewswire/ -- LG AI Research hosted its "LG AI Talk Concert 2025" today at the ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Once cautious, OpenAI, Grok, and others will now dive into giving unverified medical advice with virtually no disclaimers.

The major LLMs today are legal landmines, providing no visibility into training data that may violate copyrights, patents, ...

The global agentic AI in healthcare market is set to witness a growth rate of 35-40% in the next 5 years. Increasing demand ...